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How susceptible pigs are to infection with sheep prions 
is unknown. We show, through transmission experiments in 
transgenic mice expressing porcine prion protein (PrP), that 
the susceptibility of this mouse model to bovine spongiform 
encephalopathy (BSE) can be enhanced after its passage 
in ARQ sheep, indicating that the pathogenicity of the BSE 
agent	is	modified	after	passage	in	sheep.	Transgenic	mice	
expressing porcine PrP were, nevertheless, completely re-
sistant to infection with a broad panel of classical scrapie 
isolates from different sheep PrP genotypes and with dif-
ferent	biochemical	characteristics.	The	atypical	(Nor98	like)	
isolate (SC-PS152) was the only scrapie isolate capable of 
transmission in these mice, although with a marked trans-
mission barrier. Unexpectedly, the atypical scrapie agent 
appeared to undergo a strain phenotype shift upon trans-
mission to porcine-PrP transgenic mice and acquired new 
strain  properties,  suggesting  that  atypical  scrapie  agent 
may exhibit different phenotypes depending on the host cel-
lular PrP or other genetic factors.
T
ransmissible spongiform encephalopathies (TSEs) are 
infectious diseases that affect humans and several live-
stock species, causing fatal neurodegeneration. TSEs are 
linked to the conversion of cellular prion protein (PrPC) 
to the aberrant form associated with the disease (PrPSC). 
Sheep scrapie, the most widely known TSE (1), has been 
documented in Europe for >2 centuries and is thought to 
have spread to other countries worldwide throughout the 
1900s (2). Classical scrapie is caused by a variety of prion 
strains that can be distinguished by their biological and bio-
chemical features (3), although several so-called atypical 
scrapie strains that have remarkably different biochemical 
and  transmission  characteristics  have  been  recently  de-
scribed (4,5). Other TSEs include bovine spongiform en-
cephalopathy (BSE), which reached epidemic proportions 
in Europe at the end of the past century due to the use of 
animal feed containing BSE-contaminated feedstuffs (6). 
A human variant of BSE, called variant Creutzfeldt-Jacob 
disease (vCJD) (7), was discovered in 1994 and reported in 
1996 as linked to the BSE epidemic in the United Kingdom 
and elsewhere.
No reports exist of naturally occurring TSEs in pigs. 
However, the experimental inoculation of pigs and trans-
genic mice overexpressing porcine PrP has indicated that 
swine are susceptible to BSE infection by the parenteral 
route,  although  with  a  considerable  transmission  barrier 
(8,9). The oral transmission of BSE in pigs has not been 
demonstrated to date.
 The potential spread of BSE to animals in the human 
food chain such as sheep, goats, and pigs needs assess-
ing because a risk for human infection by animals other 
than BSE-infected cattle cannot be excluded. Moreover, 
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the use of pigs as graft donors could cause concern, given 
a recent report of vCJD in the recipient of a porcine dura 
mater graft (10).
The transmission barrier limits TSE infection between 
different  species.  Sheep  can  be  experimentally  infected 
with BSE that is not easily distinguished from some scrapie 
strains showing a 19-kDa atypical proteinase K–resistant 
PrP  (PrPres)  unglycosylated  band  (11–13).  Susceptibility 
and resistance to TSE infection in sheep is determined by 
polymorphisms at PrP amino acid positions 136, 154, and 
171; sheep have the VRQ and ARQ alleles that are most 
susceptible to scrapie infection (14). Although ARQ is con-
sidered to show the highest susceptibility to BSE infection 
(15), the ARR allele was until recently thought to confer 
full resistance to BSE and scrapie (16,17). However, the 
successful transmission of BSE prions to ARR/ARR sheep 
(18) and the detection of natural cases of classical scrapie 
in sheep with the ARR/ARR genotype (19) have shown that 
this resistance is penetrable. Moreover, the identification of 
previously unrecognized atypical scrapie strains in sheep 
with various genotypes, including ARR/ARR, further sup-
ports this statement (20,21).
Although only 1 case of BSE in a goat has been con-
firmed, several putative field cases of BSE infection af-
fecting  goats  and  sheep  have  been  detected  in  Europe, 
and the infectious properties of the resulting TSEs are not 
well known (22,23). In addition, a rise in scrapie outbreaks 
among flocks in Europe has been described; it is possible 
that some cases of alleged sheep scrapie could be ovine 
BSE. In a previous report, we demonstrated that BSE ex-
perimentally passaged in homozygous ARQ sheep showed 
enhanced infectivity (compared with cattle BSE) as deter-
mined in transgenic mice expressing bovine PrP protein 
(24).
Previous experiments showed that transgenic mice ex-
pressing porcine PrP (PoPrP-Tg001) can be infected with 
cattle BSE, but that infection is limited by a strong bar-
rier (8): only some BSE inocula were able to infect Po-
PrP-Tg001 mice in primary transmission experiments, and 
when transmission occurred only a reduced percentage of 
the inoculated mice were affected. In the present study, we 
used the PoPrP-Tg001 mouse model to compare the por-
cine PrP transmission barrier to BSE infection before and 
after passage in sheep. In parallel, we also analyzed the sus-
ceptibility of PoPrP-Tg001 mice to a broad panel of scrapie 
isolates from different ovine PrP genotypes and with differ-
ent biochemical characteristics.
Materials and Methods
Transgenic Mice
The PoPrP-Tg001 mouse line was generated and char-
acterized as previously described (8). These mice express 
porcine PrP protein under the control of the murine PrP 
promoter in a murine PrP0/0 background. The animals ex-
press ≈4× the level of porcine PrP in the brain compared 
with the levels expressed in pig brains.
TSE Isolates
Cattle BSE
Three isolates of different origins were used: cattle-
BSE1,  a  pool  of  material  from  49  BSE-infected  cattle 
brains  (TSE/08/59)  supplied  by  the  Veterinary  Labora-
tory  Agency  (New  Haw,  Addlestone,  Surrey,  UK);  cat-
tle-BSE2, material obtained from the brainstem of 1 cow 
naturally infected with BSE supplied by the same agency 
(RQ 225:PG1199/00); and cattle-BSE0, an isolate obtained 
from the brainstem of 1 cow naturally infected with BSE 
(case 139) supplied by Institut National de la Recherche 
Agronomique (INRA) (Nouzilly, France).
Sheep BSE0
Sheep BSE0 came from a pool of brainstems from 7 
ARQ/ARQ sheep experimentally infected by intracerebral 
inoculation with the same cattle-BSE0 described above. 
That work was part of the project “BSE in sheep” QLRT-
2001-01309 (INRA, Nouzilly, France).
Sheep Scrapie Isolates
Eight  scrapie  isolates  of  different  origins  and  bio-
chemical  characteristics  obtained  from  sheep  with  dif-
ferent PrP genotypes were also used in this study. These 
isolates were SC-UCD-99, obtained from the brainstem of 
an Irish ARQ/ARQ sheep naturally infected with scrapie 
(provided by the Veterinary Research Laboratory, Abbot-
stown, Ireland); SC-Langlade, obtained from the brainstem 
of an ARQ/ARQ sheep from France naturally infected with 
scrapie (provided by INRA, Toulouse, France); SC-N662-
97, obtained from the brainstem of an ARQ/ARQ sheep 
from Spain naturally infected with scrapie; SC-JR01, ob-
tained from the brainstem of an infected VRQ/VRQ sheep 
provided by J. Requena (Santiago de Compostela Univer-
sity, Santiago de Compostela, Spain); SC-PS13, obtained 
from the brainstem of an ARQ/ARQ sheep from France 
naturally infected with scrapie (provided by INRA, Tou-
louse); SC-PS48, obtained from the brainstem of a VRQ/
VRQ sheep from France naturally infected with scrapie 
(provided by INRA, Toulouse); SC-PS83, obtained from 
the brainstem of a ARR/ARR sheep from France naturally 
infected with scrapie (provided by INRA, Toulouse [19]); 
and SC-PS152, obtained from the brainstem of a AfRQ/
AfRQ sheep from France naturally infected with atypical 
(Nor98-like) scrapie (provided by INRA, Toulouse).
SC-UCD/99  adapted  to  BoPrP-Tg110  was  obtained 
after 2 subpassages of the SC-UCD-99 isolate in BoPrP-
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Tg110 mice expressing bovine PrP (24). For subpassages, 
equivalent amounts of brain homogenates from all PoPrP-
Tg001 mice collected from primary passage were pooled 
and used as inocula. Brainstem from healthy homozygous 
ARQ sheep was inoculated in PoPrP-Tg001 mice as a neg-
ative control.
All  inocula  were  prepared  in  sterile  5%  glucose  as 
10% homogenates. To minimize the risk for bacterial in-
fection, we preheated inocula for 10 min at 70ºC before 
inoculation.
Transmission Studies
Groups of 12–20 mice (6–7 weeks of age) were housed 
according to the guidelines of the Code for Methods and 
Welfare Considerations in Behavioural Research on Ani-
mals (Directive 86/609EC). Mice were inoculated in the 
right parietal lobe by using a disposable 25-gauge hypoder-
mic needle. Twenty microliters of 10% brain homogenate, 
containing similar amounts of PrPres (as estimated by West-
ern blot), was delivered to each animal.
The neurologic status of the inoculated mice was as-
sessed twice a week. The presence of 3 of 10 signs of neu-
rologic dysfunction established diagnostic criteria (25) was 
needed to score a mouse positive for prion disease. The ani-
mals were killed for ethical reasons when progression of 
the disease was evident or when considered necessary due 
to old age (650 days), and their brains were harvested for 
subsequent biochemical and histologic analysis.
PrPres Assay
Frozen brain tissue samples from mice were homog-
enized in 5% glucose in distilled water by using grinding 
tubes (Bio-Rad Laboratories, Hercules, CA, USA) and ad-
justed to 10% (wt/vol) with TeSeE Precess 48 Ribolyser 
OGER (Bio-Rad) according to the manufacturer’s instruc-
tions. Brain samples were analyzed by using the TeSeE 
Western Blot 355 1169 kit (Bio-Rad) but with some adjust-
ments for the different amount of sample used. To arrive at 
the volume proposed in the manufacturer’s recommenda-
tions, 100 μL of the 10% brain homogenates to be tested 
was supplemented with 100 μL of 10% brain homogenate 
from PrP null mice (26). Processed samples were loaded 
on  Criterion  12%  acrylamide  gels  (165.6001;  Bio-Rad) 
and  electrotransferred  to  immobilon  membranes  (IPVH 
000 10; Millipore, Billerica, MA, USA). For the immu-
noblotting experiments, Sha31 (27) and 12B2 (28) mono-
clonal antibodies (MAbs) were used at concentrations of 
1 μg/mL. Immunocomplexes were detected by horserad-
ish  peroxidase–conjugated  anti-mouse  immunoglobulin 
G (Amersham Pharmacia Biotech, Piscataway, NJ, USA). 
Immunoreactivity  was  visualized  by  chemiluminescence 
(Amersham Pharmacia Biotech).
Lesion Profiles and Paraffin-embedded Tissue Blots
All procedures involving mouse brains were performed 
as previously described (29). Briefly, samples were fixed 
in neutral-buffered 10% formalin (4% formaldehyde) be-
fore paraffin embedding. Once deparaffinated, 2 μm–thick 
tissue sections were stained with hematoxylin and eosin. 
Lesion profiles were established according to the standard 
method described by Fraser and Dickinson (30). For paraf-
fin-embedded tissue (PET) blots, the protocol described by 
Andréoletti et al. (31) was used.
Results
Biochemical Properties of TSE Isolates
Samples of each TSE isolate were processed and ana-
lyzed by Western blotting. As shown in Figure 1, PrPres in 
sheep BSE showed the characteristic unglycosylated band of 
19 kDa (32); when compared with the original cattle BSE0 
isolate, only slight differences could be observed in terms 
of the electrophoretic mobility of the PrPres, probably due to 
PrP amino acid sequence differences. ARQ/ARQ isolates 
SC-UCD/99, SC-Langlade, and SC-662/97 showed a PrPres 
unglycosylated band of 21 kDa, and isolate SC-PS13 from 
the same sheep PrP genotype showed a smaller band of 
20 kDa. The SC-JR01 and SC-PS48 isolates from a VRQ/
VRQ sheep showed unglycosylated bands of 21 kDa and 
19 kDa, respectively. An unglycosylated band of 21 kDa 
was detected in the ARR/ARR SC-PS83 isolate. Finally, 
the SC-PS152 isolate, whose genotype is widely associated 
with Nor98 cases (33,34), showed the characteristic band 
pattern of the atypical (Nor98-like) scrapies (4,35).
All  scrapie  isolates  showing  a  20–21-kDa  ungly-
cosylated  band  and  the  atypical  SC-PS152  isolate  were 
recognized  by  the  Sha31  antibody  (Figure  1,  panel  A) 
and the 12B2 antibody (Figure 1, panel B), which probe 
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Figure	1.	Electrophoretic	profiles	and	antibody	labeling	of	atypical	
proteinase  K–resistant  prion  protein  (PrPres)  detected  with 
monoclonal antibodies Sha31 (A) and 12B2 (B) in different isolates 
used for inoculating porcine PrP transgenic mice. Panels A and B 
were loaded with the same quantities of extracted PrPres from each 
sample. MW, molecular mass in kilodaltons.BSE and Scrapie in Porcine-PrP Transgenic Mice
the WGQGG epitope (amino acids 93–97 of sheep PrP). 
However, SC-PS48 and sheep-BSE (showing a 19-kDa un-
glycosylated band) were poorly recognized by 12B2 MAb 
(Figure 1, panel B), suggesting that the 12B2 epitope is not 
protected against digestion with proteinase K in these iso-
lates, as in cattle BSE.
Susceptibility of PoPrP-Tg001 Mice to TSE Isolates
To evaluate the susceptibility of PoPrP-Tg001 mice to 
ARQ sheep BSE as opposed to the original cattle BSE, the 
BSE agent was inoculated in parallel before and after passage 
in ARQ/ARQ sheep in these mice. As shown in the Table, all 
PoPrP-Tg001 mice survived the cattle BSE0 infection and 
were culled without clinical signs at 650 days postinocula-
tion (dpi), but when assessed for the presence of PrPres in the 
brain, 3 (19%) were positive. In the second passage, all mice 
died at 197 ± 4 dpi. Similar results were obtained when 2 
other BSE inocula (cattle BSE1 and cattle BSE2) were used 
(Table). In contrast, in PoPrP-Tg001 mice inoculated with 
BSE passaged in ARQ sheep (sheep BSE), an attack rate of 
100% and survival time of 458 ± 11 dpi were observed, in-
dicating that the PoPrP-Tg001 mice were fully susceptible 
to sheep BSE. Secondary subpassage in these mice led to 
a considerable reduction in the survival time (162 ± 4 dpi), 
which was maintained in subsequent subpassages. These re-
sults suggest the increased infectivity of BSE after passage 
in sheep in the PoPrP-Tg001 mouse model.
To evaluate the susceptibility of PoPrP-Tg001 mice to 
other sheep TSEs, we inoculated these mice with a panel 
of sheep scrapie isolates from different genotypes and with 
different strain properties. As shown in the Table, the atypi-
cal scrapie SC-PS152 isolate was the only one able to infect 
PoPrP-Tg001 mice at a low attack rate (16%) and survival 
time of 300 to 600 dpi. Secondary passage rendered a 100% 
attack rate and survival time of 162 ± 13 dpi. The other 
scrapie isolates included in the panel were not transmitted 
in the PoPrP-Tg001 mice either in primary or subsequent 
passages. We verified that the infectivity of the different 
scrapie isolate used in this work was sufficiently high for 
efficient transmission in transgenic mice expressing ovine 
PrP (data not shown).
PoPrP-Tg001 mice inoculated with healthy homozy-
gous ARQ sheep brain material as controls were also eu-
thanized after 600 dpi without showing clinical signs after 
first and second passages. None were positive for PrPres in 
their brains.
Biochemical Characterization of PrPres in Inoculated 
PoPrP-Tg001 Mice
PrPres  from  BSE  adapted  to  porcine  PrP  in  PoPrP-
Tg001  mice  showed  a  different  glycoprofile  than  the 
original inoculated BSE (Figure 2, panel C), although it 
preserved biochemical properties such as electrophoretic 
mobility (Figure 2, panel A) and lack of immunoreactivity 
to the 12B2 MAb (Figure 2, panel B). The 12B2 MAb is 
able to recognize porcine PrPC as confirmed by Western 
blotting when samples not treated with proteinase K are 
used (data not shown).
In  PoPrP-Tg001  mice,  cattle  BSE  and  sheep  BSE 
agents  produced  identical  PrPres  signatures  and  shared 
similar PrPres biochemical properties (Figure 2, panel A). 
These features persisted after subsequent passages (data 
not shown).
In contrast, Western blot analysis of the porcine prion 
generated through the inoculation of atypical scrapie iso-
late (SC-PS152) showed a dramatic molecular shift after 
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Table. Transmission of cattle BSE, sheep BSE, and sheep scrapie isolates in transgenic mice expressing porcine prion protein* 
First passage Second passage  Third passage
TSE isolate Genotype
PrP
res,
kDa
Survival
time, dpi
%
(Attack rate) 
Survival
time, dpi
%
(Attack rate) 
Survival
time, dpi
%
(Attack rate)
Cattle-BSE1 – 19 >650 0	(0/12)† 269 ± 3 100	(10/10) 204 ± 12 100	(9/9)
Cattle-BSE2 – 19 498 ± 9 17	(2/12)†	 198 ± 6 100	(15/15) 193 ± 17 100	(6/6)
Cattle-BSE0 – 19 >650 19	(3/16)† 197 ± 4 100	(12/12) 190 ± 10 100	(7/7)
Sheep-BSE0 ARQ/ARQ 19 458 ± 11 100	(15/15) 162 ± 4 100	(13/13) 166 ± 7 100	(7/7)
SC-662/97 ARQ/ARQ 21 >650 0	(0/10) >650 0	(0/12) ND ND
SC-UCD/99 ARQ/ARQ 21 >650 0	(0/12) >650 0	(0/9) ND ND
SC-Langlade ARQ/ARQ 21 >650 0	(0/12) >650 0	(0/12) ND ND
SC-PS13 ARQ/ARQ 20 >650 0	(0/12) >650 0	(0/12) ND ND
SC-JR01 VRQ/VRQ 21 >650 0	(0/12) >650 0	(0/12) ND ND
SC-PS83 ARR/ARR 21 >650 0	(0/12) >650 0	(0/12) ND ND
SC-PS48 VRQ/VRQ 19 >650 0	(0/9) >650 0	(0/10) ND ND
SC-PS152 AfRQ/AfRQ |7–14 300–600 16	(2/12) 162 ± 13 100	(9/9) 172 ± 16 100%	(7/7)
SC-UCD/99	adapted	
to BoPrP-Tg110
–- >650 0	(0/13) >650 0	(0/10) ND ND
Healthy sheep brain ARQ/ARQ >650 0	(0/14) >650 0	(0/9) ND ND
*BSE, bovine spongiform encephalopathy; TSE, transmissible spongiform encephalopathy; PrP
res, atypical proteinase K–resistant prion protein; dpi, days 
postinoculation;	ND,	not	determined.	
†No.	animals	positive	for	the	aberrant	form	of	PrP	associated	with	disease	/	no.	inoculated	animals.	RESEARCH
passage  in  the  porcine  PrP  mouse  model  (Figure  3).  A 
3-band PrPres pattern with an unglycosylated band of 19 
kDa, which differed substantially from the molecular signa-
ture of atypical scrapie PrPres, was observed Moreover, this 
porcine prion was indistinguishable from the porcine prion 
generated by inoculation of sheep BSE in terms of PrPres 
electrophoretic mobility (Figure 3, panel A), 12B2 MAb 
immunoreactivity (Figure 3, panel B), or its glycoprofile 
(Figure 3, panel C), characteristics that were maintained in 
subsequent passages in the same mouse model.
Lesion Profile and PrPSc Deposition Pattern  
in Inoculated PoPrP-Tg001 Mice
Brain material from PoPrP-Tg001 mice inoculated with 
the BSE-infected brains of either cattle or sheep showed 
consistent similarities in lesion profiles and PrPSc deposition 
patterns in PET blots, although some differences could be 
observed, mainly in areas G7 and G9. These features per-
sisted after a second passage in PoPrP-Tg001 mice (Figure 
4). PrPSc was also detected in the spleens of PoPrP-Tg001 
mice inoculated with either cattle BSE or sheep BSE in first 
and second passages (data not shown). In mice inoculated 
with the different classical scrapie isolates, no typical brain 
lesions associated with prion infection were detected. We 
observed no differences between animals inoculated with 
classical scrapie isolates and those inoculated with brain 
tissue from healthy homozygous ARQ sheep or noninocu-
lated PoPrP-Tg001 mice (data not shown).
Although some similarities were observed between the 
brains of PoPrP-Tg001 inoculated with SC-PS152 and the 
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Figure 2. Brain atypical proteinase K–resistant prion protein (PrPres) of porcine PrP transgenic mice infected with cattle bovine spongiform 
encephalopathy	(BSE)	(lane	2)	or	sheep	BSE	agents	(lane	4).	Electrophoretic	profiles	and	antibody	labeling	of	PrPres detected with 
monoclonal	antibodies	Sha31	(A)	or	12B2	(B).	Profiles	produced	by	cattle	(lane	1)	and	sheep	BSE	(lane	3)	before	passage	in	the	porcine	
mouse model are shown for comparison. MW, molecular mass in kilodaltons. C) Triangular plot of the glycosyl fractions of PrPres after 
proteinase K digestion and Western blotting using the Sha31 antibody. Data shown are the means of 5 or more measurements obtained 
from density scans in 2 or more Western blots. To interpret the plot, read the values for the diglycosyl, monoglycosyl, and aglycosyl 
fractions along the bottom, right and left axes of the triangle, respectively. For each point, the sum of the 3 values is 100.
Figure 3. Brain atypical proteinase K–resistant prion protein (PrPres) of porcine PrP transgenic mice infected with an atypical scrapie (SC-
PS152)	agent	(lane	4)	versus	sheep	bovine	spongiform	encephalopathy	(Sheep-BSE)	agent	(lane	2).	Electrophoretic	profiles	and	antibody	
labeling of PrPres	detected	with	monoclonal	antibodies	Sha31	(A)	or	12B2	(B).	Profiles	produced	by	atypical	scrapie	(SCPS152)	(lane	3)	
and sheep-BSE (lane 1) before passage in the porcine mouse model are shown for comparison. MW, molecular mass in kilodaltons. 
C) Triangular plot of the glycosyl fractions of PrPres after proteinase K digestion and Western blotting using the Sha31 antibody. Data 
shown are the means of >5 measurements obtained from density scans in >2 Western blots. To interpret the plot, read the values for the 
diglycosyl, monoglycosyl, and aglycosyl fractions along the bottom, right and left axes of the triangle, respectively. For each point, the sum 
of the 3 values is 100.BSE and Scrapie in Porcine-PrP Transgenic Mice
brains of those inoculated with cattle BSE and sheepBSE, 
some differences could be observed mainly in region G6 
and G8 (Figure 4, panels A–C). Moreover, PrPSC distribu-
tions in the PET blots showed some differences when com-
pared with those observed in samples from both cattle and 
sheep BSE–inoculated mice (Figure 4, panels D–F). These 
differences mainly appeared in the cortex, the medial pre-
tectal nucleus, the posterior commissure, the zona incerta 
and hypothalamic lateral area in which PrPSC deposition 
was more intense in cattle and sheep BSE–inoculated mice 
than in the SC-PS152–inoculated animals.
Discussion
In this study, transgenic mice expressing porcine PrP 
(8) were used to assess the transmission capacity of a wide 
range of TSE agents from sheep. Our results indicated that 
none of the classical scrapie isolates tested was transmitted 
to our porcine PrP mouse model after intracerebral inocula-
tion (Table), suggesting a highly (if not completely) resis-
tance to the classical scrapie strains tested independently 
of their origin and biochemical signature. The absence of 
successful transmission of the SC-PS48 isolates with an 
unglycosylated bands of 19 kDa-like BSE suggests a BSE-
unrelated origin for these BSE-like scrapie strains.
The atypical isolate SC-PS152 was the only scrapie 
isolate able to infect the Po-PrP mouse model after intrac-
erebral  inoculation  (Table),  albeit  with  a  low  efficiency 
of infection in the first passage (attack rate 16%). These 
results suggest the potential ability of atypical scrapie pri-
ons to infect pigs, although with a strong transmission bar-
rier. Given the increasing number of atypical scrapie cases 
found in Europe and in North America, the potential ability 
of atypical scrapie to adapt to the pig becoming more easily 
transmitted could raise concerns about the potential danger 
of feeding ruminant meat and bone meal to swine.
In our transmission experiments, an obviously shorter 
survival period (458 ± 11 dpi) and an increased attack rate 
(100%) were observed in PoPrP-Tg001 mice inoculated 
with sheep BSE (Table) compared with those inoculated 
with the original cattle BSE (>650 dpi, 19%). These last 
figures correlate well with those reported for other cattle 
BSE isolates (Table). Differences in survival times were 
maintained after subsequent passages in this mouse model 
(Table), suggesting that the increased infectivity of sheep 
BSE cannot be linked to a higher infectious titer in the 
initial inoculum but must be the outcome of a modifica-
tion in the pathogenicity of the agent. We can also rule out 
that the primary amino acid sequence of the ovine PrPSC 
leads to more efficient conversion of porcine PrPC because 
scrapie isolates from sheep with the same ARQ-PrP gen-
otype were not able to infect these mice (Table). Taken 
together, the increased infectivity of sheep BSE in the por-
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Figure	 4.	 Lesion	 profiles	 and	 regional	 distributions	 of	 atypical	 proteinase	 K–resistant	 prion	 protein	 (PrPres)  in  the  brain  of  porcine 
PrP transgenic mice infected, either in 1st passage (white column) or in 2nd passage (black column) with cattle bovine spongiform 
encephalopathy (BSE) (panels A and D), sheep BSE (panels B and E), or atypical scrapie (panels C and F) agents. A–C) Lesion scoring 
of	9	areas	of	gray	matter	(G)	and	white	matter	(W)	in	mice	brains:	dorsal	medulla	(G1),	cerebellar	cortex	(G2),	superior	colliculus	(G3),	
hypothalamus (G4), medial thalamus (G5), hippocampus (G6), septum (G7), medial cerebral cortex at the level of the thalamus (G8) and 
at the level of the septum (G9), cerebellum (W1), mesencephalic tegmentum (W2) and pyramidal tract (W3). Error bars indicate SE. D–F) 
Histoblots of representative coronal sections at the level of the hippocampus.RESEARCH
cine PrP mouse model must be considered as increased 
pathogenicity of the agent attributable to its passage in 
sheep. These features support previous results indicating 
that the BSE agent modifies its biological properties after 
passage in sheep, with the result that its pathogenicity in-
creases in transgenic mice expressing bovine PrP (24). An 
increased pathogenicity of ovine BSE was also reported in 
conventional RIII mice when compared with retrospective 
cattle BSE experiments (36). In other prion strains, pas-
sage through an intermediate species has also been noted 
to alter host susceptibility (37).
The enhanced infectivity of the BSE agent after its 
passage in ARQ sheep raises concern about its potential 
danger for other species, including humans. This question, 
as well as others related to the infectivity of the new por-
cine prion generated in this study, is currently being ad-
dressed in transmission experiments using transgenic mice 
expressing human PrP.
Upon  passages  in  porcine  PrP  transgenic  mice,  the 
BSE agent retained most of its biochemical properties, ex-
cept for its PrPres glycoprofile in which some differences 
were appreciable. Our comparative analysis of cattle BSE 
and sheep BSE upon transmission in porcine PrP transgen-
ic mice showed that both agents exhibit similar molecular 
(Figure 2) and neuropathologic properties (Figure 4). These 
features were preserved after subsequent passages. These 
results suggest that, despite their modified pathogenicity, 
the 2 porcine prions generated share the same biochemical 
and neuropathologic properties, regardless of whether the 
BSE agent used to inoculate the mice was obtained from 
ARQ sheep or cows. In agreement with these results, the in-
creased infectivity of sheep BSE previously observed upon 
transmission in bovine PrP transgenic mice was not reflect-
ed in its molecular or neuropathologic properties (24).
The atypical scrapie (SC-PS152) agent appeared to un-
dergo a strain phenotype shift upon transmission to porcine 
PrP transgenic mice. Surprisingly, this novel strain pheno-
type was similar to that of sheep BSE propagated in the 
same mice in terms of several features: 1) survival times 
observed after stabilization in PoPrP-Tg001 mice (second 
passages) were similar (Table); 2) PrPres molecular profiles 
of the 2 agents in porcine PrP mice were indistinguishable 
(Figure 3); and 3) vacuolation profiles observed in second 
passages largely overlapped (Figure 4).
These findings could reflect the evolutionary potential 
of prion agents upon transmission to a foreign host able 
to promote strain shift and emergence of new properties 
(38,39). The converging molecular, neuropathologic, and 
biological properties of atypical scrapie and sheep BSE 
upon propagation in porcine transgenic mice could be the 
consequence of a restriction imposed by the porcine PrPC, 
which might only admit a few options as it changes its con-
formation to PrPSC.
Our results could also suggest a common origin for 
sheep BSE and atypical scrapie agents, which may exhibit 
different phenotypes depending on the host PrPC or other 
host factors. Although this last explanation seems to be less 
likely, so far we cannot draw any definitive conclusion on 
this issue. Whichever the case, the ability of an atypical 
scrapie to infect other species and its potential capacity to 
undergo a strain phenotype shift in the new host prompts 
new concerns about the possible spread of this uncommon 
TSE in other species as a masked prion undistinguishable 
from other strains.
Acknowledgments
We thank J. Grassi for providing the Sha31 MAb, J. Lan-
geveld for providing 12B2 MAb, and Bio-Rad for supplying the 
ELISA TeSeE and TeSeE CJD components.
This  work  was  supported  by  National  Spanish  grants 
(RTA2006-00091 and AGL2005-03066) a grant from UK FSA 
(M03043) and grants from the European Union grants (QLRT-
2001-01309,  FP6-2004-FOOD3-023183,  and  CT2004-50657). 
D.P. was supported by a fellowship from the Alβan Program, and 
M.E.H. holds a fellowship awarded by the Instituto Nacional de 
Investigacion y Tecnoloigia Agraria y Alimentaria.
Dr Espinosa works in the Molecular and Cellular Biology of 
Prions Group of the Centro de Investigación en Sanidad Animal–
Instituto Nacional de Investigacion y Tecnoloigia Agraria y Ali-
mentaria, Valdeolmos, Madrid, Spain. His primary research inter-
est is the study of the elements modulating prion strain properties 
and interspecies prion transmission.
References
  1.   Pattison IH, Jones KM. The possible nature of the transmissible 
agent of scrapie. Vet Rec. 1967;80:2–9.
  2.   Detwiler LA, Baylis M. The epidemiology of scrapie. Rev Sci Tech. 
2003;22:121–43.
  3.   Bruce  ME. TSE  strain  variation.  Br  Med  Bull.  2003;66:99–108. 
DOI: 10.1093/bmb/66.1.99
  4.   Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA, Bratberg 
B. Cases of scrapie with unusual features in Norway and designation 
of a new type, Nor98. Vet Rec. 2003;153:202–8.
  5.   Buschmann A, Biacabe AG, Ziegler U, Bencsik A, Madec JY, Er-
hardt G, et al. Atypical scrapie cases in Germany and France are 
identified by discrepant reaction patterns in BSE rapid tests. J Virol 
Methods. 2004;117:27–36. DOI: 10.1016/j.jviromet.2003.11.017
  6.   Wilesmith JW, Wells GA, Cranwell MP, Ryan JB. Bovine spongiform 
encephalopathy: epidemiological studies. Vet Rec. 1988;123:638–
44.
  7.   Ironside JW, Sutherland K, Bell JE, McCardle L, Barrie C, Estebeiro 
K, et al. A new variant of Creutzfeldt-Jakob disease: neuropatho-
logical and clinical features. Cold Spring Harb Symp Quant Biol. 
1996;61:523–30.
  8.   Castilla J, Gutierrez-Adan A, Brun A, Doyle D, Pintado B, Ramirez 
MA, et al. Subclinical bovine spongiform encephalopathy infection 
in  transgenic  mice expressing  porcine  prion  protein.  J  Neurosci. 
2004;24:5063–9. DOI: 10.1523/JNEUROSCI.5400-03.2004
1220	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	15,	No.	8,	August	2009BSE and Scrapie in Porcine-PrP Transgenic Mice
  9.   Wells GA, Hawkins SA, Austin AR, Ryder SJ, Done SH, Green RB, 
et al. Studies of the transmissibility of the agent of bovine spongi-
form encephalopathy to pigs. J Gen Virol. 2003;84:1021–31. DOI: 
10.1099/vir.0.18788-0
10.   Heath CA, Barker RA, Esmonde TF, Harvey P, Roberts R, Trend 
P, et al. Dura mater-associated Creutzfeldt-Jakob disease: experi-
ence from surveillance in the UK. J Neurol Neurosurg Psychiatry. 
2006;77:880–2. 
11.   Foster JD, Dickinson AG. The unusual properties of CH1641, a 
sheep-passaged isolate of scrapie. Vet Rec. 1988;123:5–8.
12.   Hope J, Wood SC, Birkett CR, Chong A, Bruce ME, Cairns D, et al. 
Molecular analysis of ovine prion protein identifies similarities be-
tween BSE and an experimental isolate of natural scrapie, CH1641. 
J Gen Virol. 1999;80:1–4.
13.   Baron  T,  Biacabe  AG.  Molecular  behaviors  of  “CH1641-like” 
sheep scrapie isolates in ovine transgenic mice (TgOvPrP4). J Virol. 
2007;81:7230–7. DOI: 10.1128/JVI.02475-06
14.   Baylis M, Goldmann W, Houston F, Cairns D, Chong A, Ross A, 
et al. Scrapie epidemic in a fully PrP-genotyped sheep flock. J Gen 
Virol. 2002;83:2907–14.
15.   Houston F, Goldmann W, Chong A, Jeffrey M, Gonzalez L, Foster 
J, et al. Prion diseases: BSE in sheep bred for resistance to infection. 
Nature. 2003;423:498. DOI: 10.1038/423498a
16.   Hunter N. Prion protein (prnp) genotypes and natural scrapie in 
closed flocks of Cheviot and Suffolk sheep in Britain. In: Court 
LDB, editor. Transmissible subacute spongiform encephalopathies: 
prion diseases. Paris: Elsevier; 1996. p. 47–50.
17.   European Food Safety Authority. Opinion of the Scientific Panel of 
the European Food Safety Authority on the biological hazards on the 
breeding programme for TSE resistance in sheep. The EFSA Jour-
nal. 2006;382:1–46.
18.   Andreoletti O, Morel N, Lacroux C, Rouillon V, Barc C, Tabouret 
G, et al. Bovine spongiform encephalopathy agent in spleen from 
an ARR/ARR orally exposed sheep. J Gen Virol. 2006;87:1043–6. 
DOI: 10.1099/vir.0.81318-0
19.   Groschup MH, Lacroux C, Buschmann A, Luhken G, Mathey J, Ei-
den M, et al. Classic scrapie in sheep with the ARR/ARR prion gen-
otype in Germany and France. Emerg Infect Dis. 2007;13:1201–7.
20.   Le Dur A, Beringue V, Andréoletti O, Reine F, Laï TL, Baron T, 
et al. A newly identified type of scrapie agent can naturally infect 
sheep  with  resistant  PrP  genotypes.  Proc  Natl Acad  Sci  U  S A. 
2005;102:16031–6.
21.   European Union Directorate General for Health and Consumers. 
Preliminary report on the monitoring and testing of ruminants for the 
presence of transmissible spongiform encephalopathy (TSE) in the 
EU in 2007 [cited 2009 May 10] Available from http://ec.europa.eu/
food/food/biosafety/bse/preliminary_annual_report_tse2007_en.pdf
22.   Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, Lilin T, et al. 
BSE agent signatures in a goat. Vet Rec. 2005;156:523–4.
23.   The  TSE  community  reference  laboratory  strain  typing  expert 
group  (STEG).  MEMO/06/113.  2006  9/3/2006  [cited  2009  May 
10].  Available  from  http://europa.eu/rapid/pressReleasesAction.
do?reference=MEMO/06/113 
24.   Espinosa JC, Andreoletti O, Castilla J, Herva ME, Morales M, Ala-
millo E, et al. Sheep-passaged bovine spongiform encephalopathy 
agent  exhibits  altered  pathobiological  properties  in  bovine-PrP 
transgenic mice. J Virol. 2007;81:835–43. DOI: 10.1128/JVI.01356-
06
25.   Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, et al. 
Transgenic mice expressing hamster prion protein produce species-
specific scrapie infectivity and amyloid plaques. Cell. 1989;59:847–
57. DOI: 10.1016/0092-8674(89)90608-9
26.   Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, 
Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes 
mRNA  production  are  developmentally  normal.  Mol  Neurobiol. 
1994;8:121–7. DOI: 10.1007/BF02780662
27.   Féraudet C, Morel N, Simon S, Volland H, Frobert Y, Créminon C, 
et al. Screening of 145 anti-PrP monoclonal antibodies for their ca-
pacity to inhibit PrPSc replication in infected cells. J Biol Chem. 
2005;280:11247–58. 
28.   Yull  HM,  Ritchie  DL,  Langeveld  JP,  van  Zijderveld  FG,  Bruce 
ME, Ironside JW, et al. Detection of type 1 prion protein in vari-
ant Creutzfeldt-Jakob disease. Am J Pathol. 2006;168:151–7. DOI: 
10.2353/ajpath.2006.050766
29.   Andreoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, 
Lantier F, et al. PrP(Sc) accumulation in placentas of ewes exposed 
to natural scrapie: influence of foetal PrP genotype and effect on 
ewe-to-lamb transmission. J Gen Virol. 2002;83:2607–16.
30.   Fraser H, Dickinson AG. The sequential development of the brain le-
sion of scrapie in three strains of mice. J Comp Pathol. 1968;78:301–
11. DOI: 10.1016/0021-9975(68)90006-6
31.   Andreoletti O, Simon S, Lacroux C, Morel N, Tabouret G, Chabert 
A, et al. PrP(Sc) accumulation in myocytes from sheep incubating 
natural scrapie. Nat Med. 2004;10:591–3. DOI: 10.1038/nm1055
32.   Thuring CM, Erkens JH, Jacobs JG, Bossers A, Van Keulen LJ, Gars-
sen GJ, et al. Discrimination between scrapie and bovine spongiform 
encephalopathy in sheep by molecular size, immunoreactivity, and 
glycoprofile of prion protein. J Clin Microbiol. 2004;42:972–80. 
DOI: 10.1128/JCM.42.3.972-980.2004
33.   Saunders GC, Cawthraw S, Mountjoy SJ, Hope J, Windl O. PrP 
genotypes of atypical scrapie cases in Great Britain. J Gen Virol. 
2006;87:3141–9. DOI: 10.1099/vir.0.81779-0
34.   Moum T, Olsaker I, Hopp P, Moldal T, Valheim M, Benestad SL. 
Polymorphisms  at  codons  141  and  154  in  the  ovine  prion  pro-
tein  gene  are  associated  with  scrapie  Nor98  cases.  J  Gen Virol. 
2005;86:231–5. DOI: 10.1099/vir.0.80437-0
35.   Arsac JN, Andreoletti O, Bilheude JM, Lacroux C, Benestad SL, 
Baron T. Similar biochemical signatures and prion protein genotypes 
in atypical scrapie and Nor98 cases, France and Norway. Emerg In-
fect Dis. 2007;13:58–65.
36.   Gonzalez L, Chianini F, Martin S, Siso S, Gibbard L, Reid HW, et al. 
Comparative titration of experimental ovine BSE infectivity in sheep 
and mice. J Gen Virol. 2007;88:714–7. DOI: 10.1099/vir.0.82426-0
37.   Bartz JC, Marsh RF, McKenzie DI, Aiken JM. The host range of 
chronic wasting disease is altered on passage in ferrets. Virology. 
1998;251:297–301. DOI: 10.1006/viro.1998.9427
38.   Scott MR, Groth D, Tatzelt J, Torchia M, Tremblay P, DeArmond SJ, 
et al. Propagation of prion strains through specific conformers of the 
prion protein. J Virol. 1997;71:9032–44.
39.   Bartz JC, Bessen RA, McKenzie D, Marsh RF, Aiken JM. Adapta-
tion and selection of prion protein strain conformations following 
interspecies transmission of transmissible mink encephalopathy. J 
Virol. 2000;74:5542–7. DOI: 10.1128/JVI.74.12.5542-5547.2000
Address for correspondence: Juan-María Torres, Centro de Investigación 
en Sanidad Animal, 28130 Valdeolmos, Madrid, Spain; email: jmtorres@
inia.es
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	15,	No.	8,	August	2009	 1221 
Use of trade names is for identification only and does not imply  
endorsement by the Public Health Service or by the U.S.  
Department of Health and Human Services.
All material published in Emerging Infectious Diseases is in the 
public domain and may be used and reprinted without special 
permission; proper citation, however, is required.